Leading the Way in Life Science Technologies

GEN Exclusives

More »

August 1, Vol. 32, No. 14

  • Feature Articles

    • All Eyes on Molecular Imaging
    • MaryAnn Labant
    • Molecular imaging plays a key role in pharmacology evaluation and is expected to grow significantly in the future Even though preclinical imaging has proven its worth, it is still a relatively new technology Consistent paradigms have yet to be developed ... more »
    • RT-qPCR Edging Out Other Methods
    • Kathy Liszewski
    • Real-time quantitative PCR (RT-qPCR or qPCR) is revolutionizing many aspects of molecular biology and becoming the gold standard for accurate, sensitive, and fast quantification of gene expression Relatively new, it also is experiencing growing pains... more »
    • Bioreactor Market Growth Spurs Innovation
    • Vicki Glaser
    • During a year marked by global financial recessions and uncertainty, one can look to the biotech industry—the bioprocessing sector in particular—as a bright spot, with manufacturers of bioreactor and fermentor systems reporting continued strong growth... more »
    • Monoclonal Antibodies Enter Golden Age
    • Angelo DePalma
    • The diversity of development tools, an abundance of manufacturing options, and standardization of many unit operations has ushered in a golden age for monoclonal antibodies (mAbs) mAb process development and GMP manufacturing increasingly rely on platform processes involving streamlined production ... more »
  • Columns

    • Automation Pioneer Enters Life Sciences
    • Carol Potera
    • Brooks Life Science Systems is building on its expertise in robotics and cryogenics to provide state-of-the-art cold storage systems for life scientists Brooks Life Science Systems is a new division of Brooks Automation, a provider of robotic and cryogenic systems ... more »
    • New Hope for Alzheimer's Disease
    • Gail Dutton
    • The global market value of Alzheimer's disease (AD) therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease The current therapeutic market is valued at $3 to $4 billion, shared ... more »
    • Single-Use Bioreactors Get Nod
    • Eric S. Langer
    • Bioreactors are constantly evolving, with improvements being introduced rapidly To assess how the industry will be adopting and using some of these new technologies, at both clinical and commercial manufacturing scales, we asked more than 300 biomanufacturers their approaches to ... more »
    • People in the News
    • Bibby Scientific US hired Peter Lucas as president for the western hemisphere Before this appointment, Lucas served as North American director of marketing, laboratory solutions at Sartorius He has also worked for Merck KGaA Millipore... more »